Midiana (Drospirenone, Ethinylestradiol)

Drospirenone/Ethinylestradiol, the active ingredients in Midiana, are a combined oral contraceptive presented as a tablet for oral use. They prevent pregnancy in women of reproductive age by inhibiting ovulation, thickening cervical mucus, and altering the endometrial lining to reduce the chance of implantation.

GNH USA supplies Midiana as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics worldwide while adhering to stringent quality standards and regulatory requirements, and supporting healthcare professionals with reliable supply chain solutions.

Midiana, a combined oral contraceptive, is used to prevent pregnancy by modulating hormonal pathways that regulate the menstrual cycle.

Pregnancy prevention: provides reliable contraception for women of childbearing age Menstrual cycle regulation: helps achieve more predictable menstrual bleeding patterns Acne improvement: may reduce acne associated with androgenic activity in some users

Midiana may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild gastrointestinal upset - Breast tenderness: swelling or discomfort - Headache: mild to moderate - Irregular bleeding or spotting: changes in menstrual flow

Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism - Arterial thrombosis: stroke or myocardial infarction - Severe allergic reaction: anaphylaxis or angioedema

When prescribing Midiana, consider the following precautions.

Contraindications: known history of thromboembolic disorders, estrogen‑dependent tumors, or active liver disease Smoking: avoid use in women over 35 who smoke Cardiovascular risk: assess hypertension and hyperlipidemia before prescribing Pregnancy: discontinue immediately if pregnancy is confirmed Breastfeeding: consult healthcare provider before use Store at ambient temperature: keep in original packaging, protect from moisture and light

Midiana can interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampin, carbamazepine, phenytoin) may reduce contraceptive efficacy - Antifungal agents such as ketoconazole or itraconazole may increase hormone levels leading to toxicity

Moderate Interactions (Monitor Closely): - SSRIs (e.g., fluoxetine) may increase risk of mood changes - Antihypertensives (e.g., ACE inhibitors) may have altered blood pressure control - Diuretics (e.g., thiazides) may increase potassium loss when combined with drospirenone